The PE ratio for Ani Pharmaceuticals stock stands at 77.58 as of May 7, 2024. This results from the current EPS of $0.86 and stock price of $66.72.
Over the last ten years, the average PE ratio of Ani Pharmaceuticals has been 431.3. The current 77.58 PE ratio is 82% below the historical average. Over the past ten years, ANIP's PE ratio was at its highest in the Jun 2018 quarter at 6,680, with a price of $66.8 and an EPS of $0.01. The Sep 2015 quarter recorded the bottom point at 13.21, with a price of $39.51 and an EPS of $2.99.
Maximum annual increase: 429.36% in 2016
Year | PE ratio | Change |
---|---|---|
2023 | 64.12 | N/A |
2022 | N/A | N/A |
2021 | N/A | N/A |
2020 | N/A | N/A |
2019 | 120.92 | 251.82% |
2018 | 34.37 | N/A |
2017 | N/A | N/A |
2016 | 178.29 | 429.36% |
2015 | 33.68 | 55.85% |
2014 | 21.61 | N/A |
Currently, ANIP's PE ratio is below the 5 and 10-year averages.
ANIP's PE ratio is higher than its peer stocks NVS and PFE. Ani Pharmaceuticals's current PE ratio of 77.58 is above the average of its peers, which is 32.52.
Stock name | PE ratio | Market cap |
---|---|---|
RPRX Royalty Pharma plc | 11.13 | $16.9B |
NVS Novartis AG | 13.37 | $202.14B |
JAZZ Jazz Pharmaceuticals plc | 21.26 | $7.01B |
CAH Cardinal Health Inc | 43.74 | $24.29B |
PFE Pfizer Inc | 73.08 | $156.81B |
ANIP Ani Pharmaceuticals Inc | 77.58 | $1.41B |
TEVA Teva Pharmaceutical Industries Ltd | N/A | $15.64B |
CLDX Celldex Therapeutics Inc | N/A | $2.78B |
ANIP's price to earnings ratio is 77.58 as of May 7, 2024.
The 5-year average PE ratio for ANIP stock is 80.67.
Over the last ten years, the quarterly PE ratio reached a historic high of 6,680 in the Jun 2018 quarter.
ANIP's price to earnings ratio is currently 82% below its 10-year historical average.
ANIP's PE ratio is high because the stock price is relatively expensive compared to the earnings generated by the company.
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (May 7, 2024), Ani Pharmaceuticals's stock price is $66.72. The earnings per share for the trailing twelve months (TTM) ending Dec 2023 is $0.86. Therefore, Ani Pharmaceuticals's P/E ratio for today is 77.58. PE RATIO(77.58) = STOCK PRICE($66.72) / TTM EPS($0.86)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.